Slate Medicines

Slate Medicines is a biotechnology company focused on advancing the next generation of treatments for migraine and other headache disorders. The company’s lead program, SLTE-1009, is a potential first-in-class subcutaneous anti-PACAP therapy for the prevention of migraine and other headache disorders.